Profile
SYBX VRTX ALNY REGN ARGX SGEN
Company Name Synlogic, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $19.65M $100.41B $60.32B $58.82B $48.74B $43.15B
Employees 0.00K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Mary Beth Dooley Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
SYBX VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 3 1 4 3 3
Quant Rating Sell Neutral Strong Sell Buy Neutral Neutral
Trading
SYBX VRTX ALNY REGN ARGX SGEN
Last Close $1.55 $407.37 $464.95 $557.73 $799.56 $228.74
High 52 $1.78 $516.74 $482.13 $1016.53 $804.9 $228.74
Low 52 $0.97 $366.54 $224.58 $482.92 $532.27 $228.74
Price vs. 52 Week High -12.92 % -21.17 % -3.56 % -45.13 % -0.66 % 0 %
Price vs. 52 Week Low 59.79 % 11.14 % 107.03 % 15.49 % 50.22 % 0 %
Total Return
SYBX VRTX ALNY REGN ARGX SGEN
1 Month Return -2.52 % 3.31 % -0.17 % -0.41 % 5.71 % 0 %
3 Month Return 25 % -13.76 % 47.25 % -2.25 % 42.45 % 0 %
6 Month Return 40.91 % -17.84 % 93.72 % -2.22 % 31.84 % 0 %
9 Month Return 7.64 % -1.04 % 93.32 % -19.27 % 20.13 % 0 %
YTD Return 10.71 % 1.16 % 97.59 % -21.7 % 30.01 % 0 %
1 Year Return 10.71 % -15.98 % 64.11 % -45.01 % 47.1 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SYBX VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) - 11.09 % -0.43 % 4.37 % 65.28 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Growth
SYBX VRTX ALNY REGN ARGX SGEN
Asset Growth -73.76 % -0.87 %
Gross Profit Growth -99.76 % 10.25 %
Revenue Growth -99.76 % 11.66 %
Revenue 3 Year -99.86 % 45.6 %
Revenue 5 Year -99.94 % 163.93 %
Revenue 10 Year - 1632.15 %
EBIT Growth 59.22 % -93.69 %
Net Income Growth 59.22 % -114.8 %
Net Income 3 Yeari Growth Per Share 87.84 % -122.89 %
Net Income 5 Yeari Growth Per Share 92.06 % -145.38 %
Net Income 10 Yeari Growth Per Share 86.3 % 33.84 %
Operating Income Growth 25.76 % -106.08 %
Operating Cash Flow Growth (CFG) 38.66 % -113.93 %
Operating 3 Year CFG 81.66 % -118.65 %
Operating 5 Year CFG 93.06 % -131.3 %
Operating 10 Year CFG 78.95 % 12.43 %
EPS Growth 78.21 % -114.8 %
EPS Diluted Growth 78.21 % -114.97 %
Book Value Per Share -84.06 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -97.38 % 62.6 %
Share Holder 5 Year Equity Growth Per Share -98.65 % 168.85 %
Share Holder 10 Year Equity Growth Per Share 102.47 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth -100 % 116.42 %
Free Cash Flow Growth 38.89 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
SYBX VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM - 86.11 % 83.64 % 81.98 % 65.82 % 79.1 %
Return on Assets TTM -6 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -8.09 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -33.34 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 24.84 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM - 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM - 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Receivables Turnover TTM - 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM - 3.59 3.93 3.54 0.9 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.26 0.96
Fixed Asset Turnover TTM - 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM - 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -0.26 14.98 -0.12 45.13 5.67 -2.46
Free Cash Flow Per Share TTM -0.26 13.63 -0.4 36.58 5.58 -2.88
Cash Per Share TTM 138.22 % 2486.48 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM - 33.68 % -0.63 % 33.37 % 17.54 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 90.99 % 335.21 % 81.05 % 98.47 % 117.04 %
Cash Flow Coverage Ratios TTM - 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Price To Free Cash Flows Ratio TTM -6.11 28.69 -1157.98 15.3 123.13 -81.26
Price To Operating Cash Flows Ratio TTM -6.43 26.14 -3840.08 12.51 140.63 -93.1
Price Cash Flow Ratio TTM -6.43 26.14 -3840.08 12.51 140.63 -93.1
Income Statement (TTM)
SYBX VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 100% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.02B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.02B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -1.92 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
SYBX VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.01B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.01B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.02B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
SYBX VRTX ALNY REGN ARGX SGEN
Net Income $-0.02B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 34.88
AARD Aardvark Therapeutics, Inc. Common Stock 14.995
ABCL AbCellera Biologics Inc. 5.6912
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.3927
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.27
ABPWW 0.0324
ABSI Absci Corporation 3.915
ABUS Arbutus Biopharma Corporation 4.36
ABVC ABVC BioPharma, Inc. 2.99
ABVX Abivax SA American Depositary Shares 97.7585
ACAD ACADIA Pharmaceuticals Inc. 20.38
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.9486
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.175
ACIU AC Immune SA 3.23
ETFs With Exposure to SYBX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00001 328.33
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 145.74
VXF Vanguard Extended Market Index Fund 0.00006 212.275
IWC iShares Micro-Cap ETF 0.00835 157.645
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 111.2
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 111.18
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 52.46
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 52.45
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.46
DFAU Dimensional US Core Equity Market ETF 0 45.68
DFAT Dimensional U.S. Targeted Value ETF 0.000155 57.77
VTSAX Vanguard Total Stock Market Index Fund 0.00001 159.15
INNO Harbor Disruptive Innovation ETF 0 17.72
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00006 159.05
VITSX Vanguard Total Stock Market Index Fund 0.00001 159.18
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000630922 16.12
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00006 159.06
DFQTX DFA U.S. Core Equity 2 Portfolio 0 42.78
VTS.AX Vanguard US Total Market Shares Index ETF 0.00001 503.22
VEMPX Vanguard Extended Market Index InstlPlus 0.00006 392.5
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00001 298.6
Unlock